# FDA Inspection 1093235 - Aspire Independent Review Board LLC - June 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/aspire-independent-review-board-llc/43b64fc1-337d-46d9-becd-06d9988bd20d
Source feed: FDA_Inspections

> FDA Inspection 1093235 for Aspire Independent Review Board LLC on June 13, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1093235
- Company Name: Aspire Independent Review Board LLC
- Inspection Date: 2019-06-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 813012 - 2012-12-17](https://www.keypedia.com/records/fda_inspections/aspire-independent-review-board-llc/5d4ceb80-9973-456c-850b-d49e7d5e7ed0)

Company: https://www.keypedia.com/companies/aspire-independent-review-board-llc/fcbde58d-894f-491c-840d-734a8dff96e3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c